Literature DB >> 8059695

Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction.

G Sandrone1, A Mortara, D Torzillo, M T La Rovere, A Malliani, F Lombardi.   

Abstract

This study analyzed, with spectral techniques, the effects of atenolol or metoprolol on RR interval variability in 20 patients 4 weeks after the first uncomplicated myocardial infarction. Beta blocker-induced bradycardia was associated with a significant increase in the average 24-hour values of RR variance (from 13,886 +/- 1,479 to 16,728 +/- 1,891 ms2) and of the normalized power of the high-frequency component (from 22 +/- 1 to 28 +/- 2 normalized units), whereas the low-frequency component was greatly reduced (from 60 +/- 3 to 50 +/- 3 normalized units). When considering day and nighttime separately, the effects of both drugs were more pronounced in the daytime. In addition, a marked attenuation was observed in the circadian variation of the low-frequency component after beta blockade. As a result, the early morning increase of the spectral index of sympathetic modulation was no longer detectable. These results indicate that beta-blocker administration has important effects on RR interval variability and on its spectral components. The observed reduction in signs of sympathetic activation and the increase in vagal tone after beta blockade help to explain the beneficial effects of these drugs after myocardial infarction. However, the potential clinical relevance of the increase in RR variance remains to be established.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8059695     DOI: 10.1016/0002-9149(94)90400-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Heart rate variability: recent developments.

Authors:  Juha S Perkiömäki
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-04       Impact factor: 1.468

2.  Predicting the effect of D,L-sotalol on ventricular tachycardia inducibility from the RR variability response.

Authors:  B Brembilla-Perrot; P Houriez; O Claudon; J P Preiss; D Beurrier
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

3.  Heart rate variability effects of an agonist or antagonists of the beta-adrenoceptor assessed with scatterplot and sequence analysis.

Authors:  B Silke; J G Riddell
Journal:  Clin Auton Res       Date:  1998-06       Impact factor: 4.435

4.  Heart rate variability at rest and during mental stress in patients with coronary artery disease: differences in patients with high and low depression scores.

Authors:  D Sheffield; R Krittayaphong; W E Cascio; K C Light; R N Golden; J B Finkel; G Glekas; G G Koch; D S Sheps
Journal:  Int J Behav Med       Date:  1998

5.  Cardiac repolarization interval in end-stage diabetic and nondiabetic renal disease.

Authors:  M Kirvelä; L Toivonen; L Lindgren
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

6.  Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.

Authors:  C G Hanratty; B Silke; J G Riddell
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

7.  Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris.

Authors:  L Forslund; I Björkander; M Ericson; C Held; T Kahan; N Rehnqvist; P Hjemdahl
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

8.  Short-period heart rate variability in the general population as compared to patients with acute myocardial infarction from the same source population.

Authors:  Bernhard Kuch; Toma Parvanov; Hans W Hense; Joerg Axmann; Heinz D Bolte
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

9.  Impaired heart rate variability and altered cardiac sympathovagal balance after antidepressant overdose.

Authors:  W S Waring; J Y Rhee; D N Bateman; G E Leggett; H Jamie
Journal:  Eur J Clin Pharmacol       Date:  2008-06-10       Impact factor: 2.953

10.  Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease.

Authors:  Jeroen J de Hartog; Timo Lanki; Kirsi L Timonen; Gerard Hoek; Nicole A H Janssen; Angela Ibald-Mulli; Annette Peters; Joachim Heinrich; Tuula H Tarkiainen; Rene van Grieken; Joop H van Wijnen; Bert Brunekreef; Juha Pekkanen
Journal:  Environ Health Perspect       Date:  2008-08-25       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.